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The prevalence of multimorbidity in
primary care: a comparison of two
definitions of multimorbidity with two
different lists of chronic conditions in
Singapore
Eng Sing Lee1* , Poay Sian Sabrina Lee1, Ying Xie1, Bridget L. Ryan2,3, Martin Fortin4 and Moira Stewart2,3

Abstract
Background: The prevalence of multimorbidity varies widely due to the lack of consensus in defining multimorbidity.
This study aimed to measure the prevalence of multimorbidity in a primary care setting using two definitions of
multimorbidity with two different lists of chronic conditions.
Methods: We conducted a cross-sectional study of 787,446 patients, aged 0 to 99 years, who consulted a family
physician between July 2015 to June 2016. Multimorbidity was defined as ‘two or more’ (MM2+) or ‘three or more’
(MM3+) chronic conditions using the Fortin list and Chronic Disease Management Program (CDMP) list of chronic
conditions. Crude and standardised prevalence rates were reported, and the corresponding age, sex or ethnic-stratified
standardised prevalence rates were adjusted to the local population census.
Results: The number of patients with multimorbidity increased with age. Age-sex-ethnicity standardised prevalence
rates of multimorbidity using MM2+ and MM3+ for Fortin list (25.9, 17.2%) were higher than those for CDMP list
(22.0%; 12.4%). Sex-stratified, age-ethnicity standardised prevalence rates for MM2+ and MM3+ were consistently
higher in males compared to females for both lists. Chinese and Indians have the highest standardised prevalence
rates among the four ethnicities using MM2+ and MM3+ respectively.
Conclusions: MM3+ was better at identifying a smaller number of patients with multimorbidity requiring higher needs
compared to MM2+. Using the Fortin list seemed more appropriate than the CDMP list because the chronic conditions
in Fortin’s list were more commonly seen in primary care. A consistent definition of multimorbidity will help
researchers and clinicians to understand the epidemiology of multimorbidity better.
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Background
By 2050, the world’s population aged 60 years and older
is estimated to be 2 billion people [1]. Not only does a
longer life expectancy increase the chance of developing
one chronic condition, but the possibility of having multiple chronic conditions (i.e., multimorbidity) also increases. Multimorbidity poses a major challenge to the
healthcare systems as increased number of people have
multimorbidity with age [1].
Estimates for the prevalence of multimorbidity in primary care vary widely (12.9 to 95.1%) due to the inconsistencies in the definition of multimorbidity [2]. The
measurement of multimorbidity based on counting
number of chronic conditions depends on five components that are closely related to the definition of the entity: a) the types of conditions selected to form the
multimorbidity list; b) the total number of conditions
considered in the multimorbidity list; c) the cut-off
threshold for the number of chronic conditions used to
define multimorbidity; d) the data sources of the conditions; and e) the reference population being measured
[3–5]. The lack of reporting or consensus on the five
components have made comparisons between prevalence
rates found in different studies difficult, preventing reliable
estimations of disease burden and hinder resource distribution for effective disease management. Our recent work
has proposed that an ideal operational definition of multimorbidity should comprise at least 12 chronic diseases,
each with high burden and clinically relevant to the particular healthcare setting of interest [6].
The types of conditions, number of conditions and the
cut-off thresholds used are the more contentious components. There are no fixed conditions used for the multimorbidity list; the number of conditions used in
multimorbidity prevalence studies range from 4 to 147
[7]. Fortin et al. suggested a list of 20 conditions for
multimorbidity that were prevalent or had high patient
impact [8]. However, a different list of 20 conditions
under the Chronic Disease Management Programme
(CDMP) list from the Ministry of Health of Singapore
(MOH) identified for government subsidy locally may also
be suitable [9]. Although the World Health Organization
defines multimorbidity as the co-occurrence of two or
more chronic conditions in an individual [10], Fortin et al.
suggested that studies should include two operational definitions of multimorbidity, i.e., for two or more chronic
conditions and three or more chronic conditions [3].
This study sought to examine the prevalence of multimorbidity in the Singapore primary care population
using electronic medical records. The objectives of this
study were to: (1) describe the epidemiology of chronic
conditions using two lists of conditions (International
list: Fortin and Local list: CDMP) to define multimorbidity; (2) determine the crude and standardised prevalence
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rates of multimorbidity based on the two different lists
of chronic conditions with two operational definitions of
multimorbidity based on the two commonly reported
cut-off thresholds (2+ and 3+ chronic conditions); and
(3) determine the differences in the standardised prevalence rates among the different age, sex and ethnic
groups.

Methods
This was a cross-sectional study of patients aged 0 to 99
years who consulted a family physician at any of the nine
National Healthcare Group Polyclinics (NHGP) in
Singapore between 1st July 2015 and 30th June 2016 and
who had an ICD-10 (International Classification of Diseases, Tenth Revision) diagnosis code. A polyclinic is a
government-funded primary care centre that offers a
one-stop centre including chronic disease management
[11]. Data were obtained from the electronic medical records. The denominator was all patients who had consulted a family physician at least once in the stipulated
time frame.
The numerator was the number of patients that had
multimorbidity. The numerator was chosen with the following considerations. Firstly, we adopted the definition
of chronicity of a disease as lasting at least six months,
having a documented pattern of recurrence or deterioration, and having an impact on an individual’s quality of
life [12]. Secondly, we used two different lists of chronic
conditions to measure multimorbidity – a local list
(CDMP list – Additional file 1) and an international list
(Fortin list – Additional file 2). Thirdly, we used two
cut-off thresholds – ‘two or more’ chronic conditions
(MM2+) and ‘three or more’ chronic conditions (MM3+
). As such, there were four numerators: the operational
definition of MM2+ using the CDMP list (CDMP
MM2+), MM3+ using the CDMP list (CDMP MM3+),
MM2+ using the Fortin list (Fortin MM2+), and MM3+
using the Fortin list (Fortin MM3+).
We matched all the NHGP ICD-10 diagnosis codes
classified as a chronic condition to both lists because the
CDMP list was based on diagnoses stipulated on the
MOH website and the Fortin list was based on ICPC-2
(International Classification of Primary Care – 2nd edition). Four NHGP senior family physicians were consulted on the appropriateness of the matched ICD-10
codes to the two lists. They unanimously agreed on the
appropriateness of the matching of all CDMP conditions
to the ICD-10 diagnoses but found only 19 of the 20
Fortin conditions to be appropriately matched to the
ICD-10 diagnosis codes. ‘Back pain’ in the Fortin list was
not matched with the NHGP ICD-10 codes because the
condition was usually coded as an acute rather than a
chronic condition in NHGP. Ultimately, there were 26
ICD-10 codes and 39 ICD-10 codes matched to the
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CDMP and Fortin lists respectively (described in Additional file 1 and Additional file 2).
IBM SPSS version 21 and Microsoft Office Excel 2016
were used for all statistical calculations and analyses. We
described the means for continuous variables with their
respective standard deviations and proportions with
their respective confidence intervals where appropriate.
For corresponding age/sex/ethnic stratified standardised
prevalence rates, we provided the weighted average of
prevalence rate where the weights were the proportions
of persons according to the 2016 Singapore Population
[13, 14]. Confidence intervals of 95% were calculated
using the Poisson approximation around the standardised rates among the different age, sex and ethnic
groups. We considered no overlap of the 95% confidence
intervals for the standardised prevalence rates among
the different groups as statistically significant. For multiple comparisons, Bonferroni adjustment was applied.

Results
Epidemiology of chronic conditions using two lists of
conditions (CDMP and Fortin)

This study included 787,446 unique patients from nine
NHG Polyclinics. Table 1 shows the demographic characteristics of the study population compared to the national Singaporean population. The majority of the
patients in this study were in the 45–64 years age group
(32.0%). The Chinese formed the majority of the study
population (68.2%), followed by Malays (16.2%), Indians
(10.0%), and Others (5.6%). The mean age of Chinese
patients was 47.1 years (±23.3) while the mean ages of
Malay, Indian and Other patients were lower at 35.1
years (±22.1), 39.7 years (±21.1) and 37.1 (±19.1)

respectively. There were slightly more females (50.9%)
than males (49.1%). The mean age of the female patients
was older at 45.3 (±23.2) years compared to the male patients at 42.4 (±23.2) years.
The mean number of chronic conditions increased
with age. In Table 1, we observed that patients under 45
years old had fewer chronic conditions for both lists. On
the other hand, the oldest group aged 65 years and above
had the highest mean number of chronic conditions;
mean of 2.4 (±1.5) and 3.0 (±1.8) chronic conditions
when the CDMP and Fortin lists were used respectively.
The Chinese had the highest mean number of chronic
conditions (CDMP: 1.1, Fortin: 1.4), followed by the Indians (CDMP: 0.9, Fortin: 1.2), then Malays (CDMP: 0.8,
Fortin: 1.0), and lastly Others (CDMP: 0.6, Fortin: 0.8).
Table 2 reports the patient count and crude prevalence
rates of the individual chronic conditions for both lists.
The three most prevalent conditions in both lists were
‘hyperlipidaemia’, ‘hypertension’ and ‘diabetes’, with
prevalence rates above 10.0%. Additionally, the Fortin
list also identified a fourth condition, ‘Arthritis &/or
Rheumatoid Arthritis’, which also had a prevalence rate
above 10.0%. There were nine chronic conditions with
prevalence rates above 1.0% in the CDMP list compared
to 16 chronic conditions in the Fortin list.
Figures 1 and 2 report the percentage of patients with
chronic conditions based on the standardized prevalence
rate for sex and ethnicity, stratified by age. Both figures
showed that the proportion of patients with chronic
conditions increased with the advancement of age. The
CDMP list (Fig. 1) showed that 50% of the population in
primary care had one chronic condition in their late 40s,
two chronic conditions in their late 50s and three

Table 1 Demographic characteristics of the patients in the study (N = 787,446)
Number of patients (N) Percentage (%) National Proportion 2016 (%) Age (years) Number of CDMPa Number of Fortin
Conditions,
Mean (SDb) Conditions,
Mean (SDb)
Mean (SDb)
AGE
0–24 years

201,839

25.6

26.9

12.9 (8.1)

0.0 (0.2)

0.1 (0.3)

25–44 years 165,212

21.0

30.5

34.0 (6.0)

0.2 (0.6)

0.4 (0.8)

45–64 years 252,206

32.0

29.3

55.4 (5.5)

1.3 (1.3)

1.7 (1.6)

65–99 years 168,189

21.4

13.3

73.5 (7.0)

2.4 (1.5)

3.0 (1.8)

ETHNICITY
Chinese

537,234

68.2

74.3

47.1 (23.3)

1.1 (1.4)

1.4 (1.7)

Malay

127,501

16.2

13.4

35.1 (22.1)

0.8 (1.3)

1.0 (1.6)

Indian

78,452

10.0

9.1

39.7 (21.1)

0.9 (1.4)

1.2 (1.8)

Others

44,259

5.6

3.2

37.1 (19.1)

0.6 (1.1)

0.8 (1.4)

Female

400,965

50.9

51.2

45.3 (23.2)

1.0 (1.3)

1.3 (1.7)

Male

386,481

49.1

48.8

42.4 (23.2)

1.0 (1.4)

1.3 (1.7)

SEX

a

CDMP Chronic Disease Management Programme,

b

SD Standard deviation
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Table 2 Crude prevalence rates of single chronic conditions from CDMP and Fortin lists
Rank

CDMPa Conditions

Patient Count

%

Fortin Conditions

Patient Count

1

Hyperlipidaemia

257,114

32.7

Hyperlipidaemia

257,114

32.7

2

Hypertension

221,760

28.2

Hypertension

221,760

28.2

3

Diabetes

125,058

15.9

Diabetes

124,954

15.9

4

Ischaemic Heart Disease

36,401

4.6

Arthritis &/or Rheumatoid arthritis

100,838

12.8

5

Asthma

28,778

3.7

Obesity

48,893

6.2

6

Chronic Kidney Disease

21,638

2.7

Cardiovascular disease (Angina, Myocardial infarction,
Atrial fibrillation, poor circulation of lower limbs)

43,559

5.5

7

Stroke

19,808

2.5

Asthma, COPDb, or Chronic bronchitis

32,611

4.1

8

Osteoarthritis

18,378

2.3

Chronic hepatitis

25,918

3.3

9

Benign Prostate Hypertrophy

13,031

1.7

Stroke and Transient Ischaemic Attack

23,628

3.0

10

Osteoporosis

7283

0.9

Stomach problem (reflux, heartburn, or gastric ulcer)

22,233

2.8

11

Anxiety

6085

0.8

Kidney disease or failure

22,221

2.8

12

Chronic Obstructive Pulmonary
Disease (COPD)

5080

0.6

Thyroid disorder

20,781

2.6

13

Dementia

3571

0.5

Heart failure (including valve problem or replacement)

20,538

2.6

14

Schizophrenia

2889

0.4

Depression or anxiety

14,910

1.9

15

Epilepsy

2734

0.3

Chronic urinary problem

13,031

1.7

16

Rheumatoid Arthritis

2010

0.3

Any Cancer in the last 5 years

7940

1.0

17

Parkinson’s

1900

0.2

Osteoporosis

7283

0.9

%

18

Major Depression

1700

0.2

Dementia or Alzheimer’s disease

3571

0.5

19

Psoriasis

651

0.1

Colon problem (irritable bowel)

1571

0.2

20

Bipolar Disorder

51

a

CDMP Chronic Disease Management Programme,

0.0
b

COPD Chronic obstructive pulmonary disease

Fig. 1 Number of chronic conditions by age-group (CDMP list)
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Fig. 2 Number of chronic conditions by age-group (Fortin list)

chronic conditions in their early 70s. The Fortin list (Fig.
2) showed that 50% of the population in primary care
had chronic condition(s) at earlier ages i.e., one chronic
condition in their early 40s, two chronic conditions in
their early 50s, three chronic conditions in their early
60s, and four chronic conditions in their late 70s.

Prevalence rates of multimorbidity based on two
different lists with two operational definitions

The crude prevalence rates of multimorbidity in descending order were MM2+ Fortin at 33.9%, MM2+
CDMP at 29.7%, MM3 + Fortin at 23.7%, and MM3+
CDMP at 17.7%. The standardised prevalence rates of
multimorbidity were of the same order but with a
smaller magnitude after adjusting for age, ethnicity and
sex. They were 25.9% (CI 25.8, 26.0), 22.0% (CI 21.9,

22.1), 17.2% (CI 17.2, 17.3), and 12.4% (CI 12.3, 12.5)
respectively.
Differences in the standardized prevalence rates among
the different age, sex and ethnic groups

The standardised prevalence rates of multimorbidity increased with age as shown in Table 3. There were statistically significant differences among the standardised
prevalence rates of multimorbidity among all four age
groups.
The standardised prevalence rates of multimorbidity
were higher for male patients when compared to female
patients for both the CDMP and Fortin lists using both
definitions of MM2+ and MM3+ (Table 4). The differences were statistically significant.
Using the CDMP list and the MM2+ definition, the
standardised prevalence rates of multimorbidity for the

Table 3 Standardized Prevalence Rates of Multimorbidity – prevalence rates are standardised for sex and ethnicity
0–24 years

25–44 years

45–64 years

65–99 years

CPRd,
%

ASE SPRa,
% (CIc)

CPRd,
%

ASE SPRa
% (CIc)

CPRd,
%

ASE SPRa,
% (CIc)

CPRd,
%

ASE SPRa,
% (CIc)

0.16

0.13 (0.12, 0.15)

5.3

5.8 (5.6, 5.9)

40.6

37.8 (37.6, 38.1)

72.7

72.5 (72.0, 72.9)

CDMP MM 3

0.02

0.01 (0.01, 0.02)

1.7

1.9 (1.8, 2.0)

21.0

19.1 (18.9, 19.3)

49.9

49.7 (49.4, 50.0)

Fortin MMe2+

0.73

0.61 (0.58, 0.65)

8.1

8.9 (8.7, 9.0)

48.2

45.3 (45.1, 45.6)

77.5

77.3 (76.9, 77.7)

e +

0.11

0.08 0.07, 0.10)

3.7

4.0 (3.9, 4.1)

30.9

28.5 (28.3, 28.7)

61.1

60.9 (60.5, 61.2)

CDMPb MMe2+
b

e +

Fortin MM 3

ASE SPR Age-stratified, sex-and-ethnicity standardized prevalence rate,
prevalence rate, e MM Multimorbidity
a

b

CDMP Chronic Disease Management Programme, c CI Confidence interval,

d

CPR Crude
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Table 4 Standardized Prevalence Rates – prevalence rates are
standardised for age and ethnicity
Female
d

Male

CPR ,
%

SAE SPR ,
% (CIc)

CPRd,
%

SAE SPRa,
% (CIc)

29.4

20.5 (20.4, 20.6)

29.9

23.5 (23.4, 23.7)

CDMP MM 3

16.5

11.2 (11.1, 11. 3)

18.7

13.7 (13.6, 13.8)

Fortin MMe2+

34.6

25.0 (24.8, 25.1)

33.2

26.8 (26.7, 27.0)

Fortin MMe3+

24.0

16.5 (16.4, 16.6)

23.4

18.0 (17.9, 18.1)

CDMPb MMe2+
b

e +

prevalence rates of multimorbidity increased with age,
and males had a statistically significantly higher prevalence
rate of multimorbidity compared to females. There were
also differences in prevalence rates of multimorbidity in
the different ethnic groups, but the differences were
dependent on operational definitions of multimorbidity.

a

SAE SPR Sex-stratified, age-and-ethnicity standardized prevalence rate, b
CDMP Chronic Disease Management Programme, c CI Confidence interval,
CPR Crude prevalence rate, e MM Multimorbidity

Comparison with existing literature

Our standardised prevalence rates using MM2+ (22.0%
for CDMP; 25.9% for Fortin) were higher than that of
MM3+ (12.4% for CDMP; 17.2% for Fortin). This is consistent with another study that reported the agestandardised prevalence rate of two or more chronic
conditions to be higher when compared with three or
more chronic conditions [15] (26.5 and 10.2% respectively using Canada’s 1991 population as the standard
population).
There were six multimorbidity prevalence studies conducted using the definition of MM2+ in Singapore.
None of the studies described clearly how the chronic
conditions on the lists used were selected (the number
of conditions ranged from 8 to 48), and none of the
studies standardised their prevalence rate to a reference
population. The crude prevalence rates of multimorbidity ranged from 16.3 to 89.4% for different age groups
[16–21]. We compared the findings from Quah et al.
[19] which targeted older adults age 65 years and over as
it was the only study that was conducted in the primary
care setting. The mean age and standard deviation of the
participants was 73.9 (±6.5) years old which was comparable to the mean age of this study which was 73.5 (±
7.0) years old (Table 1). The authors reported that the
prevalence of multimorbidity was 89.4% which was
higher than that found in this study - MM2+ CDMP
was 72.7% and MM2+ Fortin was 77.5% (Table 3). This
difference could be attributed to the difference in the
conditions used to define multimorbidity and the data
collection methods. Quah et al. [19] used intervieweradministered questionnaire while this study used electronic medical records. Several studies have reported
variable concordance rates between questionnaire and
electronic medical records [22, 23].

a

d

different ethnic groups in descending order were Chinese, Indians, Malays and Others (Table 5). For the
MM3+ definition, the Indian ethnic group had the highest standardised prevalence rate of multimorbidity
followed by Malays, Chinese, and the Others. The ranking order of the ethnic groups based on the standardized
prevalence rates of the Fortin list was consistent for both
MM2+ and MM3+ definitions. They were Chinese,
followed by Indians, then Malays and Others. All the differences for both lists were statistically significant except
for the standardised prevalence rates for Chinese (12.5%
CI 12.4, 12.6) and Malays (12.6% CI 12.4, 12.8) using the
CDMP MM3+ definition, and the standardised prevalence rates for Chinese (17.5% CI 17.4, 17.6) and Indians
(17.5% CI 17.3, 17.8) using the Fortin MM3+ definition.

Discussion
Summary of main findings

The crude prevalence rates of multimorbidity across all
age groups ranged from 17.7 to 33.9%. The standardised
prevalence rate ranged from 12.4% (CI 12.3, 12.5) to
25.9% (CI 25.8, 26.0) with MM3 + CDMP having the
lowest standardised prevalence rate and MM2+ Fortin
having the highest. Our study showed that using different definitions and lists of conditions for multimorbidity
measurement resulted in different prevalence rates
which were statistically different from each other when
we adjusted for age, sex, and ethnicity for the same
population. Whichever lists that we used, we found that

Table 5 Standardized Prevalence Rates – prevalence rates are standardised for age and sex
Chinese
d

Malay

Indian

EAS SPR ,
% (CIc)

CPR ,
%

EAS SPR ,
% (CIc)

CPR ,
%

EAS SPR ,
% (CIc)

CPRd,
%

EAS
SPRa,
% (CIc)

33.0

22.7 (22.6, 22.8)

21.8

20.3 (20.0, 20.6)

27.2

21.2 (21.0, 21.5)

16.8

14.4 (14.1, 14.8)

CDMP MM 3

19.3

12.5 (12.4, 12.6)

14.0

12.6 (12.4, 12.8)

17.7

13.1 (12.9, 13.4)

9.6

7.7 (7.4, 7.9)

Fortin MM2+

37.6

26.8 (26.7, 26.9)

24.9

23.5 (23.2, 23.8)

31.1

24.9 (24.6, 25.2)

19.7

17.3 (16.9, 17.7)

+

26.0

17.5 (17.4, 17.6)

18.2

16.8 (16.6, 17.0)

23.0

17.5 (17.3, 17.8)

13.3

11.1 (10.8, 11.4)

b

e +

Fortin MM3

d

EAS SPR Ethnicity-stratified, age-and-sex standardized prevalence rate,
prevalence rate, e MM Multimorbidity
a

a

b

d

Others

CPR ,
%
CDMPb MMe2+

a

a

CDMP Chronic Disease Management Programme, c CI Confidence interval,

d

CPR Crude
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Our study found a higher prevalence rate of multimorbidity in males than females. However, the literature reported inconsistent differences in the prevalence rates
between the sexes. These differences could be associated
with the population source and the types of conditions
studied. For example, Fortin et al. reported that more females than males were found with multimorbidity in the
general population whereas the contrary was found in
the practice-based population [4]. Schafer et al. reported
females seemed to be more vulnerable to anxiety, depression, somatoform disorders, and pain-related morbidity while males appeared to be more vulnerable to
cardiovascular and metabolic diseases [24].
Our study was based on a practice-based population;
the distribution of single chronic conditions by prevalence
rates (> 10%) in both multimorbidity lists were dominated
by three cardiometabolic conditions (e.g. hyperlipidaemia,
hypertension, diabetes) and one degenerative-related condition e.g., arthritis and/or rheumatoid arthritis. Psychological disorders (e.g., depression or anxiety) accounted
for less than 2 % of all chronic conditions (Table 2). The
low prevalence of psychological disorders in our study
contrasted with other prevalence studies. Within the Canadian population, Ryan et al. [25] found that mood disorders were among the five most prevalent conditions in
every age group. Within the Portuguese population, Prazeres et al. [26] found that depressive disorder was the
third most prevalent condition. A likely reason for the low
prevalence of psychological disorder was the social stigma
associated with these conditions resulting in the decreased
help-seeking behaviour by the local population [27].
Singapore is a multi-ethnic country which comprises
of three main ethnic groups. However, the impact of
ethnicity on prevalence of multimorbidity remains relatively unexplored. One study by Picco et al. reported
that the crude prevalence rate of multimorbidity in Indians was higher than the Chinese and Malay [17]. This
differed from our findings where the standardized prevalence rate of multimorbidity using the same cut-off
threshold of two or more conditions was the highest in
Chinese followed by Indians and Malay. Further studies
to explore the patterns of multimorbidity among the different ethnic groups should be done.
Comparison between MM2+ and MM3+ cut-off
thresholds, and CDMP and Fortin lists

Using MM3+ as the cut-off identified a smaller number
of patients with higher needs compared to MM2+ which
was consistent for both lists and also consistent with the
findings from a systematic review [3]. The Fortin list
generated a higher prevalence rate of multimorbidity
compared to the CDMP list in the same primary care
population group. As well, the Fortin list seemed conceptually better suited for measuring multimorbidity in
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primary care. It reflected disease categories rather than
single conditions and was more sensitive to capturing
the full breadth of multimorbidity across the ages when
compared to the CDMP list. Moreover, the Fortin
list of conditions also covered all of the noncommunicable diseases listed in the global burden of
disease list for leading causes of disability-adjusted
life year in Singapore (Additional file 3). On this
basis, our study may lead to preferring Fortin’s list
for international comparative studies, but further
studies will need to be conducted to confirm our
tentative conclusion that it was indeed a more suitable operational definition of multimorbidity in the
Singapore primary care setting.
Strengths and limitations

The main limitation of the current study was that the
prevalence rates reported may be underestimated for the
following reasons. Firstly, the study only provided a
snapshot over a one-year period. Secondly, there may be
under-reporting of chronic conditions in the electronic
medical records especially for patients who seek treatment outside the polyclinics who may not have their
other medical conditions recorded in the electronic
medical records within the polyclinic system. Thirdly,
mental health conditions were probably under-reported
as we found that the prevalence was very low [27].
The major strength of the study was the rigorous mapping of ICD-10 diagnostic codes available in the primary
care EMR to two multimorbidity lists (CDMP and Fortin) with two operational definitions of multimorbidity
(MM2+ and MM3+).

Conclusions
In conclusion, this is the first study describing the prevalence of multimorbidity using a large electronic medical
record database in a Singapore primary care setting. We
compared the prevalence of multimorbidity using two
different lists of chronic conditions to measure multimorbidity. The crude prevalence rate of multimorbidity
with a cut-off threshold of three conditions was 23.7 and
17.7% based on Fortin list and CDMP list respectively.
The standardised prevalence rate was 17.2% (CI 17.2,
17.3) and 12.4% (CI 12.3, 12.5) based on Fortin list and
CDMP list respectively. We determined that the prevalence rate of multimorbidity increased with age and that
males had higher prevalence rate of multimorbidity
compared to females. We also reported differences in
the standardised prevalence rates of multimorbidity between the different ethnic groups.
We propose using three or more chronic conditions
for defining multimorbidity as the higher cut-off threshold identified a smaller number of patients with higher
needs compared to using two or more chronic

Lee et al. BMC Public Health

(2021) 21:1409

conditions. Our study results also leaned towards using
Fortin’s list as it was more sensitive to capturing the full
breadth of multimorbidity across the ages when compared to the CDMP list in the primary care setting in
Singapore.
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